Table 4. Follow up histology results for women with at least one follow up by cytology at baseline.
Follow up results | NILM | ASC-US | L-SIL | ASC-H/H-SIL | Not available | Total |
N (row%) (col%) | N (row%) (col%) | N (row%) (col%) | N (row%) (col%) | N (row%) (col%) | N (row%) (col%) | |
Total | 76 (21.9) (100) | 67 (19.3) (100) | 184 (53.0) (100) | 16 (4.6) (100) | 4 (1.2) (100) | 347 (100) (100) |
No biopsy | 60 | 57 | 149 | 10 | 4 | 280 |
(79.0) | (85.1) | (81.0) | (62.6) | (100) | (80.7) | |
CIN1 | 14 | 10 | 33 | 3 | 0 | 60 |
(18.4) | (14.9) | (17.9) | (18.7) | (0) | (17.3) | |
CIN2+ | 2 | 0 | 2 | 3 | 0 | 7 |
(2.6) | (0) | (1.1) | (18.7) | (0) | (2.0) | |
Absolute risk * | 11.7 | 3.7 | 97.7 | 6.7 | ||
95%CI | 1–42 | 0.5–13 | 20–257 | 2–16 |
CIN2+/1,000 person/years.